StonvexLoading…
StonvexStonvexStonvexCore line items from OCGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $4.41M | $4.05M | $6.04M | $4.63M |
Operating Income | $-62.92M | $-54.76M | $-65.53M | $-54.01M |
Net Income | $-67.85M | $-54.05M | $-63.08M | $-52.11M |
EPS (Diluted) | Not available | Not available | $-0.26 | $-0.22 |
Total Assets | $43.52M | $82.44M | $64.55M | $74.69M |
Total Liabilities | $55.68M | $52.81M | $23.98M | $24.89M |
Cash & Equivalents | $18.89M | $58.82M | $39.46M | $53.48M |
Free Cash Flow OCF − CapEx | $-57.15M | $-45.53M | $-72.53M | $-58.51M |
Shares Outstanding | 312.38M | 291.37M | 256.57M | 240.22M |